Dr. Bouchillon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Hunt Crt
Franklin, TN 37064Phone+1 615-599-8429Fax+1 615-410-4312
Summary
- Dr. Bouchillon received his undergraduate Bachelor of Science degree from the University of Tennessee, Knoxville and his Doctorate of Medicine from the University of Tennessee Medical Units, Memphis. Dr. Bouchillon has received his board certifications in the United States in both Pediatrics and Anesthesiology.
Dr. Bouchillon is currently the Medical Director in the department of Medical Microbiology and Vice President of International Health Management Associates, Inc., a diversified contract research organization located in Schaumburg, Illinois.
Dr. Bouchillon has published over 40 peer reviewed papers and 400 other papers and abstracts in the area of infectious disease, antimicrobial resistance and antimicrobial surveillance. Current research interests include: molecular diagnostics, molecular basis of antimicrobial resistance, and the epidemiology of resistance in respiratory and hospital acquired pathogens.
Education & Training
University of Tennessee Health Science Center College of MedicineClass of 1973
Publications & Presentations
PubMed
- 37 citationsIn Vitro Activity of WCK 5222 (Cefepime-Zidebactam) against Worldwide Collected Gram-Negative Bacilli Not Susceptible to Carbapenems.James A. Karlowsky, Meredith Hackel, Samuel K. Bouchillon, Daniel F. Sahm
Antimicrobial Agents and Chemotherapy. 2020-11-17 - 13 citationsActivity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Latin American Countries: Results from the IN...James A Karlowsky, Krystyna M Kazmierczak, Samuel K Bouchillon, Boudewijn L M de Jonge, Gregory G Stone
Antimicrobial Agents and Chemotherapy. 2019-04-01 - 20 citationsActivity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Asia-Pacific Countries: Results from the INFO...James A Karlowsky, Krystyna M Kazmierczak, Samuel K Bouchillon, Boudewijn L M de Jonge, Gregory G Stone
Antimicrobial Agents and Chemotherapy. 2018-07-01
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
